Allison Dorval

Allison Dorval

Director/Board Member at PUMA BIOTECHNOLOGY, INC.

Net worth: 736 226 $ as of 2026-06-29

50 year
Health Technology
Commercial Services
Communications

Profile

Allison Dorval is currently an Independent Director at Puma Biotechnology, Inc. since 2021.
Former positions include Independent Director at Jade Biosciences, Inc. from 2021 to 2025; Vice President & Controller at Catalent JNP, Inc. from 2016 to 2017; Chief Financial Officer at Arsenal Medical, Inc. from 2015 to 2016; Chief Financial Officer at Lyra Therapeutics, Inc. from 2015 to 2016; Chief Financial Officer at Insulet Corp.
from 2014 to 2015; Chief Financial & Accounting Officer at Verve Therapeutics, Inc. from 2021 to 2025; Chief Financial Officer at Voyager Therapeutics, Inc. from 2018 to 2021; Finance Director at Digitas, Inc.; Assistant Controller at iBASIS, Inc.; and Principal at PricewaterhouseCoopers LLP.
Education includes undergraduate studies at the University of Vermont.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-11 90,780 ( 0.18% ) 736 226 $ 2026-06-29

Allison Dorval active positions

CompaniesPositionStart
PUMA BIOTECHNOLOGY, INC. Director/Board Member 2021-07-14

Former positions of Allison Dorval

CompaniesPositionEnd
VERE THER Director of Finance/CFO 2025-07-24
JADE BIOSCIENCES, INC. Director/Board Member 2025-04-27
VOYAGER THERAPEUTICS, INC. Director of Finance/CFO 2021-10-31
JUNIPER PHARMACEUTICALS INC Comptroller/Controller/Auditor 2017-05-31
LYRA THERAPEUTICS, INC. Director of Finance/CFO 2016-07-31
See the detail of Allison Dorval's experience

Training of Allison Dorval

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Commercial Services

Communications

Commercial Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Allison Dorval